Registered entities
Axsome Therapeutics, Inc
Reg. No. 45-4241907United States
Axsome Therapeutics, Inc.
Reg. No. 1579428United States
Innovation
138 patent families (90 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 35,450 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 18 |
| 2020 | 50 |
| 2021 | 38 |
| 2022 | 48 |
| 2023 | 36 |
| 2024 | 40 |
| 2025 | 38 |
| 2026 | 18 |
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Bank & private debt | 1 | 50% |
Hiring activity
Hires frequently
21 roles tracked across 7 of the last 12 months
10 Jun 2026 · Associate Director/Director, Regulatory Affairs · New York
10 Jun 2026 · Manager, Accounts Payable · New York
1 Jun 2026 · Specialty Account Manager, Symbravo (Carmel, IN) · Carmel
1 Jun 2026 · Specialty Account Manager, Auvelity (Glendale, AZ) · Glendale
27 May 2026 · Specialty Account Manager, Auvelity (Eugene, OR) · Eugene
Based on job postings tracked across public sources.